VPI-2690B
Product Specifications
Target
Integrin, TGF-beta/Smad
Related Pathways
Stem Cells, Cytoskeletal Signaling
Bioactivity
VPI-2690B is a human-derived monoclonal antibody (mAb) that targets Integrin αVβ3. It is capable of modulating TGF-β signaling and can be utilized in research related to diabetic nephropathy.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1426776-01 0.02 mg (E-Coli)
Recombinant Pasteurella multocida Protein grpE (grpE)
Sign In for Pricing
View Details MBS1426776-02 0.1 mg (E-Coli)
Recombinant Pasteurella multocida Protein grpE (grpE)
Sign In for Pricing
View Details MBS1426776-03 0.02 mg (Yeast)
Recombinant Pasteurella multocida Protein grpE (grpE)
Sign In for Pricing
View Details MBS1426776-04 0.1 mg (Yeast)
Recombinant Pasteurella multocida Protein grpE (grpE)
Sign In for Pricing
View Details MBS1426776-05 0.02 mg (Baculovirus)
Recombinant Pasteurella multocida Protein grpE (grpE)
Sign In for Pricing
View Details MBS1426776-06 0.02 mg (Mammalian-Cell)
Recombinant Pasteurella multocida Protein grpE (grpE)
Sign In for Pricing
View Details